Additionally, De Velasco et al. reported that PIM1 levels increased in 2 mouse models of Pten-deficient PCa when treating with apalutamide as monotherapy and an even further PIM1 increase when apalutamide was combined with an Akt inhibitor [49]. The gene discussed is PTEN; the disease is posterior cortical atrophy.